Personalized treatment for hospitalized patients with breathing problems
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests a personalized approach for hospitalized patients with acute breathing problems. It uses a blood test to guide whether they receive a common steroid or a targeted medication (tocilizumab) to reduce inflammation, with the goal of improving recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have new or worsening respiratory symptoms (like cough, shortness of breath, or needing oxygen) within the last 14 days.
- You need to be admitted to the hospital for these symptoms.
- You are not currently in the ICU or needing a breathing tube (intubation).
- You are not already taking certain immunosuppressive medications (like steroids, azathioprine, or cyclophosphamide).
- You do not have active tuberculosis, severe liver problems, or very low blood counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
This trial tests if the drug tocilizumab can help treat acute chest syndrome, a serious lung complication of sickle cell disease. It is for people with sickle cell disease who are hospitalized and need oxygen or breathing support. The study compares tocilizumab to a placebo to see if it speeds up recovery.
This Phase 3 study tests tozorakimab to see if it helps people hospitalized with a viral lung infection that is causing low oxygen levels. You might qualify if you still need supplemental oxygen when the study starts.
This study compares different treatment strategies for people with rheumatoid arthritis who also have interstitial lung disease (a type of lung scarring). It aims to find the best way to manage both conditions and potentially slow lung damage.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This trial tests a new cell therapy using Treg cells from thymic tissue to calm an overactive immune response in severe COVID-19 and ARDS. It aims to improve breathing and reduce inflammation.
Hear when a new Acute Hypoxemic Respiratory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.